Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines

Wey, Jane S., Fan, Fan, Gray, Michael J., Bauer, Todd W., McCarty, Marya F., Somcio, Ray, Liu, Wenbiao, Evans, Douglas B., Wu, Yan, Hicklin, Daniel J., Ellis, Lee M. · 2005 · Cancer

Abstract

BACKGROUND: Vascular endothelial growth factor receptor‐1 (VEGFR‐1) is one of three receptor tyrosine kinases for VEGF, a key regulator of angiogenesis in cancer. Although VEGFRs initially were believed to be expressed exclusively on endothelial cells (ECs), recent studies have demonstrated the presence of VEGFR‐1 on non‐EC types. The authors hypothesized that VEGFR‐1 is present and functional in pancreatic carcinoma cells, contributing to the malignant phenotype. METHODS: The authors assessed the expression of VEGFR‐1 and its ligands in 11 pancreatic carcinoma cell lines by reverse‐transcriptase–polymerase chain reaction, enzyme‐linked immunosorbent assay, and/or Western blot analysis. The function of VEGFR‐1 was evaluated by treating two representative cell lines with VEGF‐B, a selective ligand for VEGFR‐1, and/or a specific anti‐VEGFR‐1 antibody and assessing the effects on signaling, migration, invasion, and proliferation. RESULTS: All 11 pancreatic carcinoma cell lines expressed VEGFR‐1 mRNA and protein, as well as the VEGFR‐1 ligands VEGF‐A and VEGF‐B. Two representative cell lines (L3.6 and Panc‐1) exhibited VEGF‐B‐induced mitogen‐activated protein kinase signaling. A VEGFR‐1 neutralizing antibody abrogated signaling, confirming that the ligand effect was mediated through VEGFR‐1. VEGFR‐1 stimulation by VEGF‐A or VEGF‐B was found to promote migration in both cell lines. Panc‐1 cells also demonstrated enhanced Matrigel invasion after VEGFR‐1 stimulation. VEGFR‐1‐dependent migration and invasion were blocked by the VEGFR‐1 neutralizing antibody. VEGFR‐1 activation did not appear to enhance cell proliferation. CONCLUSIONS: VEGFR‐1 appears to be expressed ubiquitously in pancreatic carcinoma cell lines, in which it induces signaling and promotes migration and invasion. Overexpression of VEGF in tumors may activate tumor cells bearing VEGFR‐1 via an autocrine pathway. Agents targeting VEGF or its receptors may have a dual inhibitory effect on tumor growth by suppressing both angiogenesis and tumor cell function. Cancer 2005. © 2005 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.21145

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 194

Metadata

Authors
Wey, J. S., Fan, F., Gray, M. J., Bauer, T. W., McCarty, M. F., Somcio, R., Liu, W., Evans, D. B., Wu, Y., Hicklin, D. J., & Ellis, L. M.
Venue
Cancer
Publisher
Wiley
Published
2005-06-10
Volume
104
Issue
2
Pages
427-438
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2012485042
Cited by
194
References
4
FWCI
8.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines. https://app.cochat.ai/papers/10.1002/cncr.21145
The paper
Wey, J. S., Fan, F., Gray, M. J., Bauer, T. W., McCarty, M. F., Somcio, R., Liu, W., Evans, D. B., Wu, Y., Hicklin, D. J., & Ellis, L. M. (2005). Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines. Cancer. https://doi.org/10.1002/cncr.21145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.